How many clinical trials are there for DHA CNS Delivery?

PlainTrial tracks 1 US clinical trials for DHA CNS Delivery, of which 1 are currently recruiting.

Which interventions appear most often on DHA CNS Delivery trial records?

LPC-EPA+DHA capsules containing omega-3 fatty acids EPA and DHA esterified to lysophosphatidylcholine (LPC-EPA+DHA)(Trade name: Lysoveta) is the most-linked intervention name on DHA CNS Delivery records (1 trial links). Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for DHA CNS Delivery?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

DHA CNS Delivery clinical trials

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed DHA CNS Delivery trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

DHA CNS Delivery: 1 US clinical trial tracked, 1 recruiting.

DHA CNS Delivery is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is University of Cincinnati, running 1 of these trials.

Enrollment posture brief

Registry condition dha-cns-delivery

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near DHA CNS Delivery

DHA CNS Delivery lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for DHA CNS Delivery on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

DHA CNS Delivery is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING NA 153 participants

Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia

University of Cincinnati

NCT06933095

Phase Distribution

Phase data not available

Top Sponsors

University of Cincinnati 1 trials

Named interventions

Most-linked intervention names on DHA CNS Delivery records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

LPC-EPA+DHA capsules containing omega-3 fatty acids EPA and DHA esterified to lysophosphatidylcholine (LPC-EPA+DHA)(Trade name: Lysoveta) Dietary supplement

1 trials

US sites by state

Facility locations filed on DHA CNS Delivery trials. A trial with sites in several states counts in each.

Ohio 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this DHA CNS Delivery page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 DHA CNS Delivery trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
University of Cincinnati sponsors the most DHA CNS Delivery trials on record, review their full trial history before evaluating a specific study. See University of Cincinnati's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This DHA CNS Delivery condition card totals 1 registered trials; most-linked intervention LPC-EPA+DHA capsules containing omega-3 fatty acids EPA and DHA esterified to lysophosphatidylcholine (LPC-EPA+DHA)(Trade name: Lysoveta); top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.